secwatch.observer — SEC 8-K summary
======================================

Issuer:     Monopar Therapeutics (MNPR)
CIK:        0001645469
Form:       8-K
Filed at:   2025-06-23T23:59:59+00:00
Accession:  0001437749-25-020959
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Monopar Therapeutics stockholders elect six directors, approve say-on-pay and auditor at annual meeting
--------------------------------------------------------------------------------

- All six director nominees elected with >3.4M votes each (excluding broker non-votes); no contest.
- Advisory say-on-pay approved: 4,382,795 for, 2,933 against, 6,840 abstain.
- Stockholders vote for annual say-on-pay frequency: 4,383,765 for every year.
- Auditor BPM LLP ratified: 5,044,817 for, 2,300 against, 1,277 abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1645469/000143774925020959/0001437749-25-020959-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1645469/000143774925020959/mnpr20250619_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-020959

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer